London, May 25, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Biologics Fill / Finish Services Market (2nd Edition) 2021 – 2030” report to its list of offerings. In pursuit of ...
Fill Finish Fill Finish Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "Fill Finish Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of ...
The fill-finish market—a traditionally stable one—is increasingly adopting new technologies. Research from our 12th Annual Report and Survey of Biopharmaceutical Manufacturing, and other studies ...
Automation, single-use systems, smaller footprints, and new drug delivery devices define trends for fill/finish outsourcing. Fill/finish operations have traditionally been among the most commonly ...
SPOKANE, Wash.--(BUSINESS WIRE)--Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological ...
As medicines shift from one-size-fits-all treatments to personalized and small-batch drugs for rare diseases, the fill/finish industry is modernizing to address changing manufacturing needs. Parallel ...
Dublin, Jan. 29, 2025 (GLOBE NEWSWIRE) -- The "Biologics Fill Finish Services Market: Industry Trends and Global Forecasts to 2035" report has been added to ResearchAndMarkets.com's offering. The ...
DUBLIN--(BUSINESS WIRE)--The "Fill Finish Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Fill Finish Service Offered, Type of FDF, ...
PCI Pharma, a Philadelphia-based CDMO, will spend $100 million to beef up aseptic liquid fill-finish manufacturing operations at its Bedford, New Hampshire, facility. The project follows PCI’s ...
The MarketWatch News Department was not involved in the creation of this content. DELRAY BEACH, Fla., Aug. 19, 2025 /PRNewswire/ -- The global Fill Finish Manufacturing Market, valued at US$16.85 ...
RAMSEY, N.J. and BOCA RATON, Fla., Sept. 08, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to ...